Visby Medical, Inc.

Visby Medical manufactures FDA-authorized at-home PCR diagnostic test kits for sexually transmitted infections (STIs). The company's flagship product is the Visby Women's At-Home STI Test Kit, which detects chlamydia, gonorrhea, and trichomoniasis with lab-quality PCR accuracy in 30 minutes without clinic visits or mail-in delays. The device combines point-of-care molecular diagnostics technology with a smartphone app for result delivery, instruction videos, and privacy-protected result viewing. Visby's tests are delivered discreetly to patients' homes with clear step-by-step instructions designed for ease of use. The company integrates telemedicine support through third-party licensed providers who can prescribe same-day treatment for positive results. Visby is trusted by major health systems including Mayo Clinic, Optum, Cedars-Sinai, Dignity Health, Mass General Brigham, and Johns Hopkins University. The product has received FDA marketing authorization and represents a significant advancement in bringing gold-standard PCR diagnostics to the consumer market. Visby's focus is on removing barriers to sexual health testing by eliminating clinic wait times, reducing stigma through at-home testing, and enabling rapid treatment initiation.